We thus first interrogated endolysosomal integrity in post-mortem AD brain tissue using an antibody against the endogenous endolysosomal marker LAMP1, performing immunofluorescence microscopy of post-mortem hippocampal sections from AD patients (n=10) and matched controls (n=10) (Table 1). The gene discussed is LAMP1; the disease is Alzheimer disease.